Hackers have reportedly taken control of Martin Shkreli's Twitter account. Suspicion that the account had been compromised emerged on Sunday when Shkreli's Twitter handle fired off a series of posts that were unusual even by the standards of the controversial former CEO of Turing Pharmaceuticals.
AstraZeneca wants its scientists to get social. The Big Pharma company is encouraging its research teams to share data and collaborate on Salesforce Chatter, an enterprise social network it thinks can support its push to eliminate silos in its R&D operation.
The deluge of uses for Apple's ResearchKit and HealthKit development tools seems to be starting in earnest. The latest entrants are a couple of apps aimed at chronic obstructive pulmonary disease (COPD) patients. One, from the non-profit COPD Foundation, hopes to enroll more than 75,000 COPD patients in a lung health research study, while the other is intended to offer the means for patients to better monitor and manage COPD.
The regulator, which has faced criticism in the past over its failure to establish a policy, set out its position in a 12-page document.
The Securities and Exchange Commission has charged a trader with using fraudulent posts on Twitter to manipulate the stock price of Sarepta Therapeutics. James Alan Craig, the man at the center of the case, is alleged to have created a Twitter account that looked like it belonged to securities research firm Citron Research and used it to post lies about Sarepta.
Life sciences will be a keystone to the newly reconceptualized Google. Under the umbrella of the parent company Alphabet, life sciences will be the first standalone company to stand shoulder to shoulder with the search engine-focused Google.
A congressman is taking aim at perceived flaws in FDA's long-awaited, much-discussed guidance on the use of Twitter.
GlaxoSmithKline has shone in a ranking of the social media savvy of the 100 largest publicly traded firms in the United Kingdom. The Big Pharma ranked second on the list, an outcome that suggests at least some drugmakers compare favorably to their peers in other industries.
Large pharma companies are posting 530% more tweets a week than in 2013, a study by Ogilvy Healthworld found. The healthcare communications group tracked the social media activity of 14 large pharma companies for one week per month over three months.
Researchers at the University of Michigan are trying to speed toward their goal of enrolling 20,000 people in a study by piggybacking onto Facebook's vast social network. And the genotypic and phenotypic data gathering project is off to a brisk start, with more than 2,000 people signing up in the days after its public launch.